Erectile dysfunction affects the ability to achieve or maintain an erection suitable for sexual activity. Levitra contains vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor prescribed for adult…
Erectile dysfunction affects the ability to achieve or maintain an erection suitable for sexual activity. Levitra contains vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor prescribed for adult men. It improves erectile response by increasing penile blood flow during sexual stimulation.
Levitra is an oral tablet containing vardenafil, a PDE5 inhibitor used for erectile dysfunction in adult men. Vardenafil supports the natural erection process rather than producing an erection without sexual stimulation. Its clinical use and safety information are described in European regulatory documentation for Levitra [1].
The active substance is vardenafil. Tablet excipients may include substances such as magnesium stearate, which helps with tablet manufacture and handling. Excipients do not provide the therapeutic effect.
Levitra is prescribed for erectile dysfunction, which means persistent difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity. Erectile difficulties may involve vascular disease, diabetes, high blood pressure, neurological conditions, medication effects, anxiety, depression, or several factors at the same time.
A clinical assessment may include cardiovascular history, current medicines, blood pressure, diabetes risk, hormone-related symptoms, and mental-health factors. Erectile dysfunction can sometimes appear before other symptoms of vascular disease, so its medical evaluation has value beyond sexual function.
Levitra is intended for adult men. It is not indicated for women or people under 18 years of age. The medicine does not prevent sexually transmitted infections and does not provide contraception.
Doctors also consider whether sexual activity itself is appropriate for a patient’s cardiovascular condition. Men with unstable angina, severe heart failure, or recent serious cardiovascular events require careful medical assessment before treatment for erectile dysfunction.
Levitra is supplied as tablets for oral administration. The dose is decided individually, taking age, other medicines, and health conditions into account. Dose selection may change when a patient has liver or kidney impairment, takes interacting medicines, or experiences adverse effects.
A high-fat meal can delay the onset of some vardenafil tablet formulations. A large meal immediately before use may therefore make the response feel slower. Grapefruit or grapefruit juice can affect enzymes involved in vardenafil metabolism and should be avoided unless a prescriber has confirmed that it is suitable.
Do not crush, chew, or alter a tablet unless the specific formulation has been designed for that method of administration. Some patients mistake a slower onset for treatment failure and take another tablet too soon; this increases the risk of adverse effects without reliably improving erectile function.
Levitra must not be used with organic nitrates, including glyceryl trinitrate or isosorbide medicines, because the combination can cause a dangerous fall in blood pressure. It is also contraindicated with riociguat, a soluble guanylate cyclase stimulator used for certain forms of pulmonary hypertension.
Caution is required with alpha-blockers, antihypertensive medicines, and substantial alcohol intake. Strong CYP3A4 inhibitors, including some medicines used for fungal infections, HIV treatment, and bacterial infections, can increase vardenafil exposure.
Severe liver impairment requires avoidance or specialist dosing decisions. Kidney impairment, advanced age, low blood pressure, and treatment with alpha-blockers may also call for a lower starting dose.
Levitra is not suitable for you if you:
The most frequently reported adverse effects of vardenafil include headache, flushing, nasal congestion, indigestion, dizziness, and visual disturbances. FDA prescribing information identifies headache and flushing among common reactions in clinical studies [2].
These effects are usually related to vasodilation. Headache may improve as the body adjusts, but severe or persistent pain requires medical review. Nasal congestion can feel like a blocked nose or facial pressure. Drinking alcohol at the same time may worsen dizziness and reduce erectile response.
Stop sexual activity and seek urgent medical attention for:
Priapism, meaning a prolonged and often painful erection, can damage erectile tissue if treatment is delayed. It is an emergency even when the erection is not associated with severe pain.
Sexual stimulation causes the release of nitric oxide in penile tissues. This activates cyclic guanosine monophosphate, or cGMP, which relaxes smooth muscle in the corpus cavernosum and allows more blood to enter the penis.
PDE5 breaks down cGMP. Vardenafil inhibits PDE5, allowing cGMP activity to persist for longer. The result is improved smooth-muscle relaxation and increased local blood flow when sexual stimulation is present.
Vardenafil does not raise sexual desire directly. It also does not treat low testosterone, infertility, or relationship-related causes of reduced sexual interest.
Several practical mistakes can reduce the apparent benefit of Levitra:
A further mistake is judging the treatment after one poorly timed attempt. Response can vary with stress, fatigue, alcohol, relationship circumstances, and the interval between food and administration.
PDE5 inhibitors share a basic mechanism, but their active substances differ in onset, duration, food effects, and interaction profiles. The comparison below uses active ingredients rather than commercial brands.
| Active ingredient | Main pharmacological feature | Practical distinction |
|---|---|---|
| Vardenafil | PDE5 inhibition | Used around planned sexual activity; food and interacting medicines can affect exposure |
| Sildenafil | PDE5 inhibition | Often used around planned activity; a high-fat meal may delay absorption |
| Tadalafil | PDE5 inhibition with longer functional duration | May provide a longer window of responsiveness and has a different dosing pattern |
Vardenafil and sildenafil have similar therapeutic roles but are not interchangeable milligram for milligram. Tadalafil remains active for longer, which some patients prefer when they want less precise timing. Its longer duration also means that adverse effects or interactions may persist for a longer period.
Vardenafil may be unsuitable for men taking medicines that strongly inhibit CYP3A4, the enzyme involved in its metabolism. It also requires special caution in men with certain heart-rhythm conditions because vardenafil can affect the QT interval. A prescriber may choose another approach after reviewing electrocardiogram findings and current treatment.
The closest alternative depends on the patient’s cardiovascular status, sexual activity pattern, other medicines, and response to previous treatment. A change from one PDE5 inhibitor to another should not involve taking both during the same period.
In clinical practice, doctors usually judge a PDE5 inhibitor by erection quality, timing, tolerability, and the patient’s cardiovascular risk rather than by one isolated attempt. A response may be disappointing when the dose is taken after heavy food, when sexual stimulation is limited, or when anxiety and alcohol interfere.
Treatment success also depends on correcting factors that reduce vascular function. Diabetes, smoking, obesity, high blood pressure, and poor sleep can weaken the response over time. The European Association of Urology places erectile dysfunction within wider sexual and cardiovascular health assessment [3].
A doctor may review the diagnosis if erections are absent in every setting, if libido is very low, or if symptoms began soon after a new medicine. The treatment plan may then include cardiovascular testing, medication review, hormone assessment, or psychological support.
Use of organic nitrates for angina rules out Levitra because the combination can produce a dangerous fall in blood pressure. Riociguat is another absolute contraindication. FDA prescribing information from 2022 also warns against combining vardenafil with nitrates and recommends careful assessment of cardiovascular fitness for sexual activity. A history of serious heart disease, prolonged QT, or previous vision loss associated with a PDE5 inhibitor requires a specific medical decision before treatment. A prescriber should review these risks before treatment.
Heavy meals may delay absorption of some vardenafil tablets, while substantial alcohol intake can worsen dizziness and reduce erection quality. Smoking, poor sleep, uncontrolled diabetes, high blood pressure, and low physical activity can also impair erectile function. WHO cardiovascular-health guidance published in 2023 links tobacco exposure, metabolic disease, and inactivity with vascular risk that can affect sexual function [4]. Regular activity, weight management, moderation of alcohol, and control of blood pressure and glucose can support treatment response.
Levitra is intended for adult men and is not indicated for people under 18. Erectile difficulties in an adolescent require assessment of physical health, mental health, development, medicines, and safeguarding factors rather than self-treatment with a PDE5 inhibitor. EMA product information from 2009 restricts the established indication to adult men with erectile dysfunction. A tablet should never be shared with a minor, even when the adult user has tolerated it well.
Vardenafil, sildenafil, and tadalafil all inhibit PDE5, but they have different pharmacokinetic profiles and interaction considerations. Tadalafil generally provides a longer period of responsiveness, while vardenafil and sildenafil are more closely associated with use around planned sexual activity. NICE clinical guidance published in 2023 describes PDE5 inhibitors as options selected according to patient preference, response, contraindications, and medicine interactions [5]. The products should not be combined, and their doses cannot be converted directly.
Older adults may use vardenafil when their cardiovascular status, kidney function, liver function, and current medicines have been assessed. Age alone does not automatically prohibit treatment, but exposure and blood-pressure effects may be more pronounced in some older patients. Alpha-blockers, antihypertensives, and medicines that inhibit CYP3A4 deserve close review. Starting-dose decisions should account for age, other medicines, and health conditions rather than relying on a standard assumption. The EMA product information from 2009 supports individualized dosing and medical review.
Stop sexual activity and obtain urgent medical care for chest pain, fainting, severe breathlessness, sudden vision loss, sudden hearing loss, or an erection lasting more than four hours. Severe allergic symptoms also require immediate treatment. Do not take another PDE5 inhibitor while symptoms are being assessed. HPRA safety information published in 2024 for PDE5 inhibitors identifies prolonged erection, major sensory changes, and serious cardiovascular symptoms as reasons for urgent evaluation.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Treating one condition does not automatically treat the other. Dapoxetine affects serotonin reuptake and has its own contraindications and interaction risks, including concerns with other serotonergic medicines and medicines that can lower blood pressure. Combining treatments requires a clinician-led review.
Anxiety about sexual performance can worsen erection quality even when penile blood flow is adequate. Alcohol can increase this problem by reducing arousal, impairing coordination, and lowering blood pressure. Addressing alcohol intake, sleep, diabetes control, smoking, and cardiovascular fitness may improve the response to PDE5 treatment.
Based on 5 reviews
I used the prescribed tablet before an evening with my partner. The first attempt was less noticeable than expected, but the next time I avoided a heavy meal and had a clearer response. I experienced mild facial warmth that faded within an hour.
4 Nov 2026Levitra helped me maintain an erection more reliably after several attempts. I had a blocked nose and a headache on the first occasion, so I reduced alcohol and discussed the timing with my prescriber. The side effects were manageable after that.
8 Oct 2026I took a tablet after a large dinner and thought it had not worked. I did not repeat the dose. A later attempt with lighter food produced a better result, although I still noticed some flushing.
15 Oct 2026The medicine improved firmness, but dizziness made me uncomfortable when I stood up quickly. My doctor reviewed my blood-pressure tablets and changed the plan. I did not continue using it without that review.
25 Oct 2026I expected an automatic erection and was disappointed during the first use. After understanding that sexual stimulation was still needed, the response became more useful. I occasionally had nasal congestion, but no serious symptoms.
11 Oct 2026
